| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The protective effect of African IgG antibodies against Plasmodium falciparum malaria was investigated by passive transfer in Thai patients. Sera from 333 African adults were collected in the Cote d'Ivoire and subjected to extensive screening. One hundred fifty-three samples were discarded for safety reasons, and IgG was extracted from those remaining under conditions allowing their use by the intravenous (iv) route.
Eight Thai patients with P. falciparum parasitemia were treated by iv inoculation of the IgG: six with a 100 mg/kg dose given over three days, one with a single 20 mg/kg dose, and one with a single 200 mg/kg dose. To ensure a safety margin of at least 48 hours, subjects were chosen among patients having a recrudescent parasitemia following quinine treatment failure at the RI level. At that stage, symptoms were mild or absent and parasitemia was low but increasing (range 4, 200–9,000/µl).
The IgG pool exerted a profound, stage-specific, but non-sterilizing effect on each of the strains tested, and proved to be safe. Asexual parasitemia decreased by a mean 728-fold (range 46–1,086), while gametocytes were unaffected. Clearance of parasites and symptoms was as fast or faster than with drugs, and was consistent in the eight patients treated, suggesting that target antigens were equally expressed in geographically remote isolates. In peripheral blood smears, no mature forms were seen at any time during the followup, which does not support the hypothesis that reversal of cytoadherence occurred.
After the disappearance of the transferred antibodies, recrudescent parasites from three patients were found to be susceptible to the same extent (mean decrease of 1,310-fold) to the same IgG preparation, indicating that selection of parasites able to escape the effect of antibodies had not occurred. No adverse side-effects were detected during the followup, which lasted one year.
This article has been cited by other articles:
|
|
 |
|
  I. Nebie, A. Diarra, A. Ouedraogo, I. Soulama, E. C. Bougouma, A. B. Tiono, A. T. Konate, R. Chilengi, M. Theisen, D. Dodoo, et al. Humoral Responses to Plasmodium falciparum Blood-Stage Antigens and Association with Incidence of Clinical Malaria in Children Living in an Area of Seasonal Malaria Transmission in Burkina Faso, West Africa Infect. Immun., February 1, 2008; 76(2): 759 - 766. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Ford, C. A. Lobo, M. Rodriguez, M. G. Zalis, R. L. D. Machado, A. R. B. Rossit, C. E. Cavasini, A. A. R. Couto, P. A. Enyong, and S. Lustigman Differential Antibody Responses to Plasmodium falciparum Invasion Ligand Proteins in Individuals Living in Malaria-Endemic Areas in Brazil and Cameroon Am J Trop Med Hyg, November 1, 2007; 77(5): 977 - 983. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Gray, P. H. Corran, E. Mangia, M. W. Gaunt, Q. Li, K. K.A. Tetteh, S. D. Polley, D. J. Conway, A. A. Holder, T. Bacarese-Hamilton, et al. Profiling the Antibody Immune Response against Blood Stage Malaria Vaccine Candidates Clin. Chem., July 1, 2007; 53(7): 1244 - 1253. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Aide, Q. Bassat, and P. L Alonso Towards an effective malaria vaccine Arch. Dis. Child., June 1, 2007; 92(6): 476 - 479. [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Clatworthy, L. Willcocks, B. Urban, J. Langhorne, T. N. Williams, N. Peshu, N. A. Watkins, R. A. Floto, and K. G. C. Smith Systemic lupus erythematosus-associated defects in the inhibitory receptor Fc{gamma}RIIb reduce susceptibility to malaria PNAS, April 24, 2007; 104(17): 7169 - 7174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Jafarshad, M. H. Dziegiel, R. Lundquist, L. K. Nielsen, S. Singh, and P. L. Druilhe A Novel Antibody-Dependent Cellular Cytotoxicity Mechanism Involved in Defense against Malaria Requires Costimulation of Monocytes Fc{gamma}RII and Fc{gamma}RIII J. Immunol., March 1, 2007; 178(5): 3099 - 3106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Narum, S. A. Ogun, A. H. Batchelor, and A. A. Holder Passive Immunization with a Multicomponent Vaccine against Conserved Domains of Apical Membrane Antigen 1 and 235-Kilodalton Rhoptry Proteins Protects Mice against Plasmodium yoelii Blood-Stage Challenge Infection. Infect. Immun., October 1, 2006; 74(10): 5529 - 5536. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Lundquist, L. K. Nielsen, A. Jafarshad, D. SoeSoe, L. H. Christensen, P. Druilhe, and M. H. Dziegiel Human Recombinant Antibodies against Plasmodium falciparum Merozoite Surface Protein 3 Cloned from Peripheral Blood Leukocytes of Individuals with Immunity to Malaria Demonstrate Antiparasitic Properties. Infect. Immun., June 1, 2006; 74(6): 3222 - 3231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. A. Lusingu, A. T. R. Jensen, L. S. Vestergaard, D. T. Minja, M. B. Dalgaard, S. Gesase, B. P. Mmbando, A. Y. Kitua, M. M. Lemnge, D. Cavanagh, et al. Levels of Plasma Immunoglobulin G with Specificity against the Cysteine-Rich Interdomain Regions of a Semiconserved Plasmodium falciparum Erythrocyte Membrane Protein 1, VAR4, Predict Protection against Malarial Anemia and Febrile Episodes. Infect. Immun., May 1, 2006; 74(5): 2867 - 2875. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Buffet, G. Milon, V. Brousse, J.-M. Correas, B. Dousset, A. Couvelard, R. Kianmanesh, O. Farges, A. Sauvanet, F. Paye, et al. Ex vivo perfusion of human spleens maintains clearing and processing functions Blood, May 1, 2006; 107(9): 3745 - 3752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. OUMA, C. C. KELLER, D. A. OPONDO, T. WERE, R. O. OTIENO, M. F. OTIENO, A. S. S. ORAGO, J. M. ONG'ECHA, J. M. VULULE, R. E. FERRELL, et al. ASSOCIATION OF FC{gamma} RECEPTOR IIA (CD32) POLYMORPHISM WITH MALARIAL ANEMIA AND HIGH-DENSITY PARASITEMIA IN INFANTS AND YOUNG CHILDREN Am J Trop Med Hyg, April 1, 2006; 74(4): 573 - 577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Layez, P. Nogueira, V. Combes, F. T. M. Costa, I. Juhan-Vague, L. H. P. da Silva, and J. Gysin Plasmodium falciparum rhoptry protein RSP2 triggers destruction of the erythroid lineage Blood, November 15, 2005; 106(10): 3632 - 3638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Bai, M. Becker, A. Gupta, P. Strike, V. J. Murphy, R. F. Anders, and A. H. Batchelor Structure of AMA1 from Plasmodium falciparum reveals a clustering of polymorphisms that surround a conserved hydrophobic pocket PNAS, September 6, 2005; 102(36): 12736 - 12741. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. John, R. A. O'Donnell, P. O. Sumba, A. M. Moormann, T. F. de Koning-Ward, C. L. King, J. W. Kazura, and B. S. Crabb Evidence That Invasion-Inhibitory Antibodies Specific for the 19-kDa Fragment of Merozoite Surface Protein-1 (MSP-119) Can Play a Protective Role against Blood-Stage Plasmodium falciparum Infection in Individuals in a Malaria Endemic Area of Africa J. Immunol., July 1, 2004; 173(1): 666 - 672. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
